163 related articles for article (PubMed ID: 12502138)
1. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India.
Acharya SK; Batra Y; Saraya A; Hazari S; Dixit R; Kaur K; Bhatkal B; Ojha B; Panda SK
Natl Med J India; 2002; 15(5):267-8. PubMed ID: 12502138
[TBL] [Abstract][Full Text] [Related]
2. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
4. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
5. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
6. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India.
Dhotial A; Kapoor D; Kumar N
Trop Gastroenterol; 2002; 23(4):170-1. PubMed ID: 12833702
[TBL] [Abstract][Full Text] [Related]
8. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
9. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
10. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study.
Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.
Arguedas MR; Johnson A; Eloubeidi MA; Fallon MB
Hepatology; 2001 Jul; 34(1):28-31. PubMed ID: 11431730
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK
Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation.
Arslan M; Wiesner RH; Poterucha JJ; Gross JB; Zein NN
Liver Transpl; 2000 Mar; 6(2):191-5. PubMed ID: 10719019
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis A virus antibodies in patients with chronic liver diseases.
López Serrano A; Antón Conejero MD; Alcaraz Soriano MJ; García del Castillo G; Gómez Pajares F; Moreno-Osset E
Rev Esp Enferm Dig; 2000 Aug; 92(8):508-17. PubMed ID: 11084818
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis a virus antibody in chronic diffuse liver disease.
Dávid K; Halmy L
Acta Med Hung; 1983; 40(2-3):147-53. PubMed ID: 6669444
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
